Back to calendar
Galmed Pharmaceuticals Ltd. (GLMD) Earnings
GLMD reports earnings on Thursday, July 30, 2026
earnings report
July 30, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.39
Actual EPS: $-0.38
EPS surprise: 0.00%
Company overview
Market Cap$4.3M
PriceUSD 0.56
EPS (TTM)-2.00
52-week high2.34
52-week low0.41
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees6